Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CTNNB1 |
Variant | E55K |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | CTNNB1 E55K does not lie within any known functional domains of the Ctnnb1 protein (UniProt.org). The functional effect of E55K is conflicting, as it has been reported to be associated both with and without nuclear accumulation of Ctnnb1 in patient samples (PMID: 10213482), and a Ctnnb1 peptide with E55K results in reduced phosphorylation by Ck1 in an in vitro assay (PMID: 12925738), and therefore, its effect on Ctnnb1 protein function is unknown. |
Associated Drug Resistance | |
Category Variants Paths |
CTNNB1 mutant CTNNB1 E55K |
Transcript | NM_001098210.2 |
gDNA | chr3:g.41224675G>A |
cDNA | c.163G>A |
Protein | p.E55K |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_005264886 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
XM_006712985 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
XM_017005738 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
XM_006712985.2 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
XM_024453358.1 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
XM_017005738.1 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
NM_001098209.1 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
NM_001904.3 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
XM_024453356.1 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
NM_001098209 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
XM_047447478.1 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
NM_001098209.2 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
XM_006712985.1 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
XM_047447479.1 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
XM_024453357.1 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
NM_001904.4 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
NM_001904 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
XM_017005738.2 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
NM_001098210 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
XM_047447477.1 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
XM_024453356.2 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
XM_047447481.1 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
XM_047447483.1 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
XM_047447480.1 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
NM_001098210.2 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
NM_001098210.1 | chr3:g.41224675G>A | c.163G>A | p.E55K | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|